Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet and Commencement of Subsequent Offering

Amgen ("Amgen")

announced today that all conditions to the closing of the tender offer by a  wholly owned subsidiary, "Merger Sub", to acquire all outstanding shares of common stock of Micromet, Inc.

for $11.00 per share in cash have been satisfied.